Onartuzumab with or without bevacizumab in combination with...

Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancer

Borin, Marie T., Chen, Meng, Mocci, Simonetta, Rubets, Igor, Chittenden, Jason, Aldairy, Wassim, Stroh, Mark
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
75
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2652-0
Date:
February, 2015
File:
PDF, 1.04 MB
english, 2015
Conversion to is in progress
Conversion to is failed